Efficacy and safety of autologous haematopoietic stem cell transplantation versus alemtuzumab, ocrelizumab, ofatumumab or cladribine in relapsing remitting multiple sclerosis (StarMS): protocol for a randomised controlled trial.
Gavin BrittainJennifer PetrieKate E M DuffyRachel GloverKatie HullockDiana PapaioannouElisa RoldánColette BeecherMatthew BursnallOlga CiccarelliAlasdair J ColesCindy CooperGavin GiovannoniIan GabrielMajid KazmiCharalampia KyriakouRichard NicholasDavid PalingAndy PeniketNeil ScoldingEli SilberThushan I de SilvaAnnalena VenneriStephen J WaltersCarolyn Anne YoungPaolo A MuraroBasil SharrackJohn A Snowdennull nullPublished in: BMJ open (2024)
ISRCTN88667898.